At the core of MD Anderson’s approach to exceptional patient care is a virtuous cycle of innovation that's grounded in collaboration, connectivity and data-based science. Our unique environment and vast resources accelerate novel concepts faster than ever before by offering leading scientific minds close proximity to our clinics to ease collaboration with our renowned clinicians and our patient partners.
At the American Association for Cancer Research Annual Meeting, our experts will showcase their pacesetting research and join colleagues from across the globe for discussion on the latest advances in cancer science.
Below are highlights from our presentations, details about onsite networking opportunities with our experts and information on open research positions at MD Anderson.
Featured Articles
Featured Abstract
HER2 targeted therapy shows promise in previously treated lung cancers
First-in-human Beamion LUNG-1 study of zongertinib
New data presented by John Heymach, M.D., Ph.D., at AACR 2025 demonstrated promising results and a manageable safety profile for zongertinib, an oral HER2-targeted therapy for patients with HER2-mutant non-small cell lung cancer. Data from this trial prompted a priority review of zongertinib by the FDA earlier this year and initiated a Phase II trial comparing it to the current standard of care.
Featured Podcast
Navigating skin side effects of targeted cancer therapy
Epidermal Growth Factor Receptor (EGFR) inhibitors are effective treatments for certain cancers, such as lung and colorectal cancer. However, they frequently cause skin-related side effects that can impact patient quality of life and adherence to treatment. Anisha Patel, M.D., and Christine Parseghian, M.D., discuss why these skin side effects occur, introduce a potential new treatment option, and share practical tips to help patients manage them. Learn more about this episode and other podcast episodes
Meet the Experts
Visit us at Booth 2527 to discuss hot topics and emerging trends with leading minds in cancer science.
Exhibit Hall Hours
Sunday, April 27: noon–5 p.m.
Monday, April 28: 9 a.m.–5 p.m.
Tuesday, April 29: 9 a.m.–5 p.m.
Wednesday, April 30: 9 a.m.–noon
Barista-crafted coffee available at the booth during all hours of the exhibit hall.
Sunday, April 27
12:30–1 p.m.
Interventions for adverse effects of EGFR inhibitors
Anisha Patel, M.D.
Associate Professor, Dermatology
2–2:30 p.m.
Clinical Trials at MD Anderson
Christopher Flowers, M.D.
Division Head, Cancer Medicine
Jennifer Litton, M.D.
Vice President, Clinical Research
Professor, Breast Medical Oncology
2:30–3 p.m.
Student Opportunities at MD Anderson
Adam Grippin, M.D., Ph.D.
Jillian Gunther, M.D., Ph.D.
Program Director, Med Students SOAR and RADAR
Marites Melancon, Ph.D.
Program Director, Med Students SOAR
Vickie Shannon, M.D.
Professor, Pulmonary Medicine
3–3:30 p.m.
Spatialomics: Mapping the Tumor Ecosystem
Anirban Maitra, M.B.B.S.
Professor, Pathology and Translational Molecular Pathology
Linghua Wang, M.D, Ph.D.
Associate Professor, Genomic Medicine
Di Zhao, Ph.D.
Assistant Professor, Experimental Radiation Oncology
3–3:30 p.m.
Cancer Vaccines: The Current Landscape
Eduardo Vilar-Sanchez, M.D., Ph.D.
Chair ad interim, Clinical Cancer Prevention
Jason Willis, M.D., Ph.D.
Assistant Professor, Gastrointestinal (GI) Medical Oncology
Monday, April 28
Tuesday, April 29
Our research by the numbers
$1.3B
invested in research
1,556
clinical trials
188
patents awarded
From Sept. 1, 2023 to Aug. 31, 2024
Education and Training at MD Anderson
MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to postdoctoral training.
More AACR News
AACR: Researchers share promising results from MD Anderson...
ABSTRACTS: CT012, CT132, CT265
Researchers from The University of Texas MD Anderson Cancer Center will present promising results...
AACR: MD Anderson’s John Weinstein elected Fellow of the...
CHICAGO ― John N. Weinstein, M.D., Ph.D., chair of Bioinformatics and Computational Biology and professor of Systems Biology at The...
AACR: Five MD Anderson researchers honored with 2025...
Five scientists from The University of Texas MD Anderson Cancer Center will be recognized with Scientific Achievement Awards and...
Clinical Trial Abstracts
Breakthroughs in cancer treatment
Showcasing our Cycle of Innovation
Institutes at MD Anderson
James P. Allison Institute
Institute for Cell Therapy Discovery & Innovation
Institute for Data Science in Oncology
Why Houston?
As America's fourth largest city, Houston has a lot to offer. Find out why Houston is a hub for scientific and medical excellence.